Collegium Pharmaceutical (COLL) Net Equity Issued and Repurchased (2015 - 2017)
Collegium Pharmaceutical (COLL) posted quarterly Net Equity Issued and Repurchased of $24.9 million for Q4 2017, down 70.94% year-over-year from $85.7 million in Q4 2016, and down 70.94% quarter-over-quarter from $85.7 million in Q4 2016.
Collegium Pharmaceutical (COLL) Net Equity Issued and Repurchased (2015 - 2017) Analysis & Trends
Collegium Pharmaceutical's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $24.9 million for Q4 2017.
- In Q4 2017, Net Equity Issued and Repurchased fell 70.94% year-over-year to $24.9 million; the TTM figure through Dec 2017 stood at $111.1 million (down 19.12% YoY), while the FY2018 annual figure was -$30000.0, down 100.09% from the prior year.
- Net Equity Issued and Repurchased for Q4 2017 stood at $24.9 million, down from $85.7 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $85.7 million in Q4 2016, with the low at $445000.0 in Q3 2016.
- The 3-year median for Net Equity Issued and Repurchased is $50.0 million (2015), against an average of $42.5 million.
- The sharpest annual moves came in 2016 and 2017: Net Equity Issued and Repurchased increased 2.35% in 2016, then tumbled 70.94% in 2017.
- Collegium Pharmaceutical's Net Equity Issued and Repurchased stood at $50.0 million in 2015, then surged by 71.44% to $85.7 million in 2016, then sank by 70.94% to $24.9 million in 2017.
- Business Quant data shows COLL's Net Equity Issued and Repurchased at $24.9 million in Q4 2017, $85.7 million in Q4 2016, and $445000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.87 Mn | 748.55 Mn | 110.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 24.91 Mn |
| Dec 31, 2017 | 24.91 Mn |
| Dec 31, 2016 | 85.72 Mn |
| Dec 31, 2016 | 85.72 Mn |
| Sep 30, 2016 | 445,000.00 |
| Sep 30, 2016 | 445,000.00 |
| Mar 31, 2016 | 51.17 Mn |
| Mar 31, 2016 | 51.17 Mn |
| Mar 31, 2015 | 50.00 Mn |
| Mar 31, 2015 | 50.00 Mn |